Requires health care practitioners prescribing opioid medications on first-time basis, or to minor children, to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Impact
The bill is expected to significantly influence state laws surrounding prescription practices, particularly those related to Schedule II controlled substances. By establishing a seven-day supply limit, the bill aims to minimize the potential for misuse and dependency, particularly among first-time users and vulnerable populations such as minors. Health care practitioners will also be required to discuss the risks associated with opioid medications with patients or their guardians before prescribing them. This additional conversation is intended to foster greater awareness of opioid risks and the rationale for their necessity, thereby promoting informed decision-making.
Summary
Assembly Bill A1651 aims to reform the prescription of opioid medications by imposing stricter limitations on initial prescriptions. Specifically, it mandates that any health care practitioner prescribing opioid medications for the first time to an adult or for a minor must restrict the supply to a maximum of seven days. This legislation is a targeted effort to curtail the over-prescription of opioids and combat the ongoing opioid crisis affecting many communities. Such a move reflects a growing concern over opioid addiction and the need for more responsible prescribing practices.
Contention
While the bill enjoys support among proponents who advocate for stricter controls on opioid prescriptions, it has also faced criticisms. Some healthcare providers express concerns that the limitations may hinder their ability to effectively manage patients' acute or chronic pain, particularly in cases where longer prescriptions may be clinically appropriate. Furthermore, the requirement for additional documentation regarding the justification for exceeding the seven-day limit may impose administrative burdens on practitioners. As this legislation progresses, it will likely spark debates over the balance between curbing addiction and ensuring adequate pain management.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Relates to prescribing opioids to a minor; prohibits practitioners from prescribing to a minor more than a seven day supply of any controlled substance containing an opioid; requires practitioners to obtain written parental consent before issuing a first prescription of a controlled substance containing an opioid to a minor; establishes exceptions.
Prohibiting healthcare providers from prescribing medication, administering diagnostic tests or conducting ongoing behavioral health treatments to minors except in certain circumstances.
Requires county health departments to maintain reserve stock of opioid antidotes to dispense to certain entities on interim basis to ensure uninterrupted supply.
Requires county health departments to maintain reserve stock of opioid antidotes to dispense to certain entities on interim basis to ensure uninterrupted supply.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.